Cancer Friends Network  

Go Back   Cancer Friends Network > Types of Cancer > Multiple Myeloma/Other Plasma Cell Neoplasms



Tim Pearson

Reply
 
LinkBack Thread Tools Display Modes
  #1 (permalink)  
Old 06-03-2010, 04:08 PM
Administrator
 
Join Date: Sep 2008
Posts: 47,390
Default YM BioSciences raises US$3.2 million in support of JAK 1/2 program



-Proceeds to support acceleration of CYT387 Phase II myelofibrosis study- read more
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote


Tim Pearson

Reply


Tim Pearson


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On


Similar Threads
Thread Thread Starter Forum Replies Last Post
BIND Biosciences announces $12.4 million Series C-1 financing cancerfr Vaginal Cancer 0 07-01-2010 07:45 PM
EntreMed Raises Additional $3 Million to Further Support Clinical Development of ENMD cancerfr Ovarian Cancer 0 04-19-2010 02:21 AM
EntreMed Raises Additional $3 Million to Further Support Clinical Development of ENMD cancerfr Ovarian Cancer 0 04-16-2010 08:46 PM


All times are GMT. The time now is 05:26 AM.


Games |Inkjet Ink Cartridges | Wall Street Journal | Torrent Search | Mortgage | Stocks | Games | Submit Articles Prices Compare | Prices Tracker | Prices Comparison Shopping
Legal: Privacy Policy and Terms of Use | RSS Feeds
Powered by vBulletin® Version 3.8.2
Copyright ©2000 - 2012, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.2.0
CancerFriends.net